Kirsten Vang Nielsen

Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group

Ann Knoop, Helle Knudsen, Eva Balslev et al. · Journal of Clinical Oncology · 2005 · 323 citations · Full text

A Prospective Randomized Comparison of 6 and 12 Cycles of Cyclophosphamide, Adriamycin, and Cisplatin in Advanced Epithelial Ovarian Cancer: A Danish Ovarian Study Group Trial (DACOVA)

K. Bertelsen, Anders Jakobsen, I. Strøyer et al. · Gynecologic Oncology · 1993 · 154 citations

Medicine, Metronomic Therapy, Gynecology +6

Sex-specific telomere length profiles and age-dependent erosion dynamics of individual chromosome arms in humans

S. Mayer, Silke Brüderlein, Sven Perner et al. · Cytogenetic and Genome Research · 2006 · 150 citations

The value of<i>TOP2A</i>gene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D

Kirsten Vang Nielsen, Bent Ejlertsen, Susanne Möller et al. · Acta Oncologica · 2008 · 111 citations · Full text

Quantifying Telomere Lengths of Human Individual Chromosome Arms by Centromere-Calibrated Fluorescence in Situ Hybridization and Digital Imaging

Sven Perner, Silke Brüderlein, Cornelia Hasel et al. · American Journal Of Pathology · 2003 · 108 citations · Full text

Chromatin, Chromosome Dynamics, Telomere Lengths +11